U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07038070) titled 'Via, a Hyaluronic Acid (HLA) Based Vaginal Moisturizer Study' on June 18.
Brief Summary: This study aims to evaluate whether the administration of vaginal estrogen along with Via, a hyaluronic acid-based vaginal moisturizer, offers superior relief from symptoms of genitourinary syndrome of menopause (GSM) in the urogynecologic patient population, compared to administration of vaginal estrogen alone.
Study Start Date: July 01
Study Type: INTERVENTIONAL
Condition:
Genitourinary Syndrome of Menopause (GSM)
Intervention:
DRUG: Vaginal estrogen tablet
The dosage of the vaginal estrogen will be one 10mcg tablet administered vaginal...